These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 17044198)

  • 1. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.
    Kaufmann SH; Baumann S; Nasser Eddine A
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1068-79. PubMed ID: 17044198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Strategies for the development of new tuberculosis vaccines].
    Fattorini L
    Minerva Med; 2007 Apr; 98(2):109-19. PubMed ID: 17519853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tuberculosis vaccination strategies based on understanding the immune response.
    Kaufmann SH
    J Intern Med; 2010 Apr; 267(4):337-53. PubMed ID: 20433580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in tuberculosis vaccine development.
    Baumann S; Nasser Eddine A; Kaufmann SH
    Curr Opin Immunol; 2006 Aug; 18(4):438-48. PubMed ID: 16777396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculous vaccine development: a perspective for the endemic world.
    Verma I; Grover A
    Expert Rev Vaccines; 2009 Nov; 8(11):1547-53. PubMed ID: 19863247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen.
    Skeiky YA; Dietrich J; Lasco TM; Stagliano K; Dheenadhayalan V; Goetz MA; Cantarero L; Basaraba RJ; Bang P; Kromann I; McMclain JB; Sadoff JC; Andersen P
    Vaccine; 2010 Jan; 28(4):1084-93. PubMed ID: 19896449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New vaccines for the prevention of tuberculosis.
    von Reyn CF; Vuola JM
    Clin Infect Dis; 2002 Aug; 35(4):465-74. PubMed ID: 12145732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis vaccines: past, present and future.
    Martin C
    Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis vaccine.
    Sarhan MA
    Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should a new tuberculosis vaccine be administered intranasally?
    Källenius G; Pawlowski A; Brandtzaeg P; Svenson S
    Tuberculosis (Edinb); 2007 Jul; 87(4):257-66. PubMed ID: 17321797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future vaccination strategies against tuberculosis: thinking outside the box.
    Kaufmann SH
    Immunity; 2010 Oct; 33(4):567-77. PubMed ID: 21029966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.